Liver Associates of Texas, PA

Houston, Texas 77030

1 studies enrolling now · 16 studies all time

What they study most

Biliary Cirrhosis, Primary, Decompensated Cirrhosis, Fibrosis, Hepatic Cirrhosis, Hepatic Fibrosis, Hepatitis C, Liver Cirrhosis, Liver Diseases, Liver Fibroses, Liver Fibrosis, Liver Inflammation, Liver Steatoses

Studies at this site

• A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis — Recruiting now
• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) — Running, not enrolling
• Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) — Completed
• A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis — Completed
• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis — Completed
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) — Completed
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early
• A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV — Completed
• Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis — Completed
• Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis — Status unconfirmed
• Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL) — Completed
• Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing — Completed